Published in Int J Gynecol Cancer on July 01, 2009
Transcatheter arterial embolization of acute arterial bleeding in the upper and lower gastrointestinal tract with N-butyl-2-cyanoacrylate. J Vasc Interv Radiol (2013) 2.21
A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. Mol Endocrinol (2010) 1.94
Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma. Cancer Sci (2008) 1.83
CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration. Arterioscler Thromb Vasc Biol (2010) 1.60
High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway. Clin Cancer Res (2012) 1.56
White matter lesions in panencephalopathic type of Creutzfeldt-Jakob disease: MR imaging and pathologic correlations. AJNR Am J Neuroradiol (2004) 1.42
Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta. Drug Metab Dispos (2004) 1.41
Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging. Eur Radiol (2007) 1.25
Ovarian metastasis in carcinoma of the uterine cervix. Gynecol Oncol (2005) 1.24
Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary. Obstet Gynecol (2002) 1.18
Pallidoreticular damage in acute carbon monoxide poisoning: diffusion-weighted MR imaging findings. AJNR Am J Neuroradiol (2005) 1.18
Predicting time to ovarian carcinoma recurrence using protein markers. J Clin Invest (2013) 1.17
Diagnostic accuracy of diffusion-weighted imaging in differentiating benign from malignant ovarian lesions. J Magn Reson Imaging (2008) 1.14
Ovarian carcinomatosis: how the radiologist can help plan the surgical approach. Radiographics (2012) 1.13
Minichromosome maintenance protein 7 in colorectal cancer: implication of prognostic significance. Int J Oncol (2008) 1.12
White matter changes in elderly people: MR-pathologic correlations. Magn Reson Med Sci (2006) 1.11
Clinicopathological characteristics of mucinous adenocarcinoma of the ovary. Gynecol Oncol (2009) 1.07
Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary. Jpn J Cancer Res (2002) 1.05
Primary fourth ventricular meningioma: a case report of an adult male. Clin Imaging (2012) 1.04
Glutathione peroxidase 3 is a candidate mechanism of anticancer drug resistance of ovarian clear cell adenocarcinoma. Oncol Rep (2008) 1.03
Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary. Int J Gynecol Cancer (2014) 1.03
Haplotype-oriented genetic analysis and functional assessment of promoter variants in the MDR1 (ABCB1) gene. J Pharmacol Exp Ther (2004) 1.02
Diagnostic accuracy of the apparent diffusion coefficient in differentiating benign from malignant uterine endometrial cavity lesions: initial results. Eur Radiol (2007) 1.02
Cerebral cortical and white matter lesions in chronic hepatic encephalopathy: MR-pathologic correlations. AJNR Am J Neuroradiol (2005) 1.01
Adjuvant chemotherapy with irinotecan hydrochloride and cisplatin for clear cell carcinoma of the ovary. Oncol Rep (2006) 1.01
Regulation of autophagy and its associated cell death by "sphingolipid rheostat": reciprocal role of ceramide and sphingosine 1-phosphate in the mammalian target of rapamycin pathway. J Biol Chem (2012) 1.00
Multidrug resistance gene-1 is a useful predictor of Paclitaxel-based chemotherapy for patients with ovarian cancer. Gynecol Oncol (2002) 1.00
Distinction between glioma progression and post-radiation change by combined physiologic MR imaging. Neuroradiology (2009) 0.99
Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging. Neuroradiology (2012) 0.99
Impact of body mass index on clinical outcome in patients hospitalized with congestive heart failure. Circ J (2011) 0.99
A randomized Phase II/III trial of 3 weekly intraperitoneal versus intravenous carboplatin in combination with intravenous weekly dose-dense paclitaxel for newly diagnosed ovarian, fallopian tube and primary peritoneal cancer. Jpn J Clin Oncol (2010) 0.98
CT-guided transthoracic needle biopsy using a puncture site-down positioning technique. AJR Am J Roentgenol (2006) 0.98
PEA-15 induces autophagy in human ovarian cancer cells and is associated with prolonged overall survival. Cancer Res (2008) 0.98
Objective evaluation of the alleviating effects of Goshajinkigan on peripheral neuropathy induced by paclitaxel/carboplatin therapy: A multicenter collaborative study. Exp Ther Med (2011) 0.98
A case of atrioventricular block (Wenckebach type) induced by sugammadex. J Anesth (2012) 0.98
Expression of the c-myc gene as a predictor of chemotherapy response and a prognostic factor in patients with ovarian cancer. Cancer Sci (2004) 0.97
Low-grade fibromyxoid sarcoma of the small bowel mesentery: computed tomography and magnetic resonance imaging findings. Radiat Med (2008) 0.95
Cell-associated beta-xylosidase from Aureobasidium pullulans ATCC 20524: Purification, properties, and characterization of the encoding gene. J Biosci Bioeng (2010) 0.95
Phase II study of intraperitoneal carboplatin with intravenous paclitaxel in patients with suboptimal residual epithelial ovarian or primary peritoneal cancer: a Sankai Gynecology Cancer Study Group Study. Int J Gynecol Cancer (2009) 0.93
Surgical principles for managing stage IB2, IIA2, and IIB uterine cervical cancer (Bulky Tumors) in Japan: a survey of the Japanese Gynecologic Oncology Group. Int J Gynecol Cancer (2014) 0.93
Checkpoint kinase inhibitor AZD7762 overcomes cisplatin resistance in clear cell carcinoma of the ovary. Int J Gynecol Cancer (2014) 0.92
Inhibiting the mTOR pathway synergistically enhances cytotoxicity in ovarian cancer cells induced by etoposide through upregulation of c-Jun. Clin Cancer Res (2011) 0.92
Cyclin A-associated kinase activity is needed for paclitaxel sensitivity. Mol Cancer Ther (2005) 0.92
Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: a potential treatment strategy. Cancer Sci (2008) 0.92
Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin. Gynecol Oncol (2011) 0.92
Clinicopathologic features of brain metastases from gynecologic malignancies: a retrospective study of 139 cases (KCOG-G1001s trial). Gynecol Oncol (2012) 0.92
Questionnaire survey of the current status of radical trachelectomy in Japan. Int J Clin Oncol (2010) 0.91
Chemical library screening for WNK signalling inhibitors using fluorescence correlation spectroscopy. Biochem J (2013) 0.91
PTEN-positive and phosphorylated-Akt-negative expression is a predictor of survival for patients with advanced endometrial carcinoma. Oncol Rep (2005) 0.91
Laminar cortical necrosis in adrenal crisis: sequential changes on MRI. Brain Dev (2007) 0.91
Putaminal lesion in multiple system atrophy: postmortem MR-pathological correlations. Neuroradiology (2008) 0.91
PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative chemotherapy. Int J Cancer (2002) 0.90
Diffusion-weighted imaging of uterine endometrial stromal sarcoma: a report of 2 cases. J Comput Assist Tomogr (2010) 0.90
Nedaplatin: a cisplatin derivative in cancer chemotherapy. Cancer Manag Res (2013) 0.90
Novel mechanism of reduced proliferation in ovarian clear cell carcinoma cells: cytoplasmic sequestration of CDK2 by p27. Gynecol Oncol (2011) 0.89
Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis. Int J Clin Oncol (2007) 0.89
Mechanisms of cisplatin resistance in clear cell carcinoma of the ovary. Oncology (2002) 0.89
Germ cell specific protein VASA is over-expressed in epithelial ovarian cancer and disrupts DNA damage-induced G2 checkpoint. Gynecol Oncol (2008) 0.89
MEK1/2 inhibitor selumetinib (AZD6244) inhibits growth of ovarian clear cell carcinoma in a PEA-15-dependent manner in a mouse xenograft model. Mol Cancer Ther (2011) 0.89
The impact of complete surgical staging upon survival in early-stage ovarian clear cell carcinoma: a multi-institutional retrospective study. Int J Gynecol Cancer (2009) 0.88
Immunohistochemical expression of geminin in colorectal cancer: Implication of prognostic significance. Oncol Rep (2009) 0.88
Extensive screening system using suspension array technology to detect mitochondrial DNA point mutations. Mitochondrion (2010) 0.88
Regulation of cell migration by sphingomyelin synthases: sphingomyelin in lipid rafts decreases responsiveness to signaling by the CXCL12/CXCR4 pathway. Mol Cell Biol (2012) 0.87
Leptomycin B enhances CDDP-sensitivity via nuclear accumulation of p53 protein in HPV-positive cells. Cancer Sci (2003) 0.87
Effect of p53 gene transfer and cisplatin in a peritonitis carcinomatosa model with p53-deficient ovarian cancer cells. Gynecol Oncol (2002) 0.87